11-6319175-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_145040.3(CAVIN3):āc.774G>Cā(p.Glu258Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,529,558 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145040.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAVIN3 | NM_145040.3 | c.774G>C | p.Glu258Asp | missense_variant | 2/2 | ENST00000303927.4 | NP_659477.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAVIN3 | ENST00000303927.4 | c.774G>C | p.Glu258Asp | missense_variant | 2/2 | 1 | NM_145040.3 | ENSP00000307292.3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152238Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000496 AC: 9AN: 181504Hom.: 0 AF XY: 0.0000627 AC XY: 6AN XY: 95756
GnomAD4 exome AF: 0.0000218 AC: 30AN: 1377202Hom.: 0 Cov.: 29 AF XY: 0.0000281 AC XY: 19AN XY: 677024
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152356Hom.: 1 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2023 | The c.774G>C (p.E258D) alteration is located in exon 2 (coding exon 2) of the PRKCDBP gene. This alteration results from a G to C substitution at nucleotide position 774, causing the glutamic acid (E) at amino acid position 258 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at